Fenwick represented Evidation Health, a company that measures health in everyday life and enables anyone to participate in ground-breaking research and health programs, in its $153 million Series E growth financing.
The round was co-led by OMERS Growth Equity and Kaiser Permanente Group Trust. Existing investors, including McKesson Ventures and B Capital Group, also participated.
Evidation will use this additional capital to fuel the expansion of virtual health programs on its Achievement ™ platform, the largest digital health network in the United States. These new programs will provide personalized insights and tools to motivate and empower individuals to take evidence-supported actions to manage their health and conditions. More information can be obtained from the company’s announcement.
The Fenwick transaction team was led by corporate partner Michael Esquivel and included associates Ryan McRobert, Noah Johnson and David Heckman.